Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Pharmaceutical and Biomedical Analysis|September 15, 2007
Enantioselective liquid chromatography-mass spectrometry assay for the determination of ifosfamide and identification of the N-dechloroethylated metabolites of ifosfamide in human plasmaRegina V Oliveira, Joelle M Onorato, Danuta Siluk, et al.
Cancer Chemotherapy and Pharmacology|May 2, 2003
Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancerStacy S Shord, Stephanie R Faucette, Heidi H Gillenwater, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2004
Regulation of CYP2B6 in primary human hepatocytes by prototypical inducersStephanie R Faucette, Hongbing Wang, Geraldine A Hamilton, et al.
Anti-Cancer Drugs|May 29, 2004
Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategyCeleste Lindley, Thomas Shea, Jeannine McCune, et al.
Anticancer Research|August 15, 2002
Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicityStacy S Shord, Stephen A Bernard, Celeste Lindley, et al.
American Journal of Clinical Oncology|June 1, 2005
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasoneCeleste Lindley, Susan Goodin, Jeannine McCune, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytesCeleste Lindley, Geraldine Hamilton, Jeannine S McCune, et al.
Cancer Investigation|October 6, 2005
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancerHeidi H Gillenwater, Jeannine S McCune, Celeste Lindley, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2007
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumorsThomas E Stinchcombe, Mark A Socinski, Christine M Walko, et al.
Pageof 2